Compactin production studies using Penicillium brevicompactum under solid-state fermentation conditions

Appl Biochem Biotechnol. 2009 Nov;159(2):505-20. doi: 10.1007/s12010-008-8461-3. Epub 2008 Dec 20.

Abstract

In the present study, compactin production by Penicillium brevicompactum WA 2315 was optimized using solid-state fermentation. The initial one factor at a time approach resulted in improved compactin production of 905 microg gds(-1) compared to initial 450 microg gds(-1). Subsequently, nutritional, physiological, and biological parameters were screened using fractional factorial and Box-Behnken design. The fractional factorial design studied inoculum age, inoculum volume, pH, NaCl, NH(4)NO(3), MgSO(4), and KH(2)PO(4). All parameters were found to be significant except pH and KH(2)PO(4). The Box-Behnken design studied inoculum volume, inoculum age, glycerol, and NH(4)NO(3) at three different levels. Inoculum volume (p = 0.0013) and glycerol (p = 0.0001) were significant factors with greater effect on response. The interaction effects were not significant. The validation study using model-defined conditions resulted in an improved yield of 1,250 microg gds(-1) compactin. Further improvement in yield was obtained using fed batch mode of carbon supplementation. The feeding of glycerol (20% v/v) on day 3 resulted in further improved compactin yield of 1,406 microg gds(-1). The present study demonstrates that agro-industrial residues can be successfully used for compactin production, and statistical experiment designs provide an easy tool to improve the process conditions for secondary metabolite production.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Algorithms
  • Bioreactors / microbiology*
  • Cell Culture Techniques / methods*
  • Computer Simulation
  • Fermentation
  • Lovastatin / analogs & derivatives*
  • Lovastatin / isolation & purification
  • Lovastatin / metabolism
  • Models, Biological*
  • Penicillium / classification
  • Penicillium / metabolism*
  • Species Specificity

Substances

  • mevastatin
  • Lovastatin